Editas Medicine
EDIT
$1.16
Share price
-7.20%
Change (1 day)
-84.07%
Change (1 year)
Operating Margin for Editas Medicine (EDIT)
Operating Margin as of April 2025 (TTM): -739.39%
According to Editas Medicine 's latest financial reports and stock price the company's current Operating Margin is -739.39%. At the end of 2024 the company had an Operating Margin of -733.72%.
Operating Margin history for Editas Medicine from 2016 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -733.72% | 274.11% |
| 2023 | -196.13% | -82.46% |
| 2022 | -1,118.26% | 48.39% |
| 2021 | -753.61% | 489.57% |
| 2020 | -127.82% | -80.38% |
| 2019 | -651.43% | 89.21% |
| 2018 | -344.28% | -60.72% |
| 2017 | -876.49% | -45.41% |
| 2016 | -1,605.53% | -64.12% |
| 2015 | -4,475.14% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | -19.96% | -97.30% | Jersey |
 | -25.89% | -96.50% | 🇺🇸 USA |
 | -10,150.00% | 1,272.75% | 🇺🇸 USA |
 | -129.00% | -82.55% | 🇬🇧 UK |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.